Erythropoietin treatment in patients with myelodysplastic syndrome and anemia.

@article{Kurzrock1991ErythropoietinTI,
  title={Erythropoietin treatment in patients with myelodysplastic syndrome and anemia.},
  author={Razelle Kurzrock and Moshe Talpaz and E H Estey and Susan M O'Brien and Zeev Estrov and Jordan U. Gutterman},
  journal={Leukemia},
  year={1991},
  volume={5 11},
  pages={985-90}
}
Hematological disorders are commonly complicated by anemia, and the symptoms of red cell deficiency adversely affect the quality of life. Erythropoietin is a glycoprotein which controls red blood cell production. Recombinant human erythropoietin, 50 U/kg/day, was given subcutaneously to 16 patients with myelodysplastic syndrome and anemia. All but one patient was transfusion dependent. Diverse pretreatment endogenous serum erythropoietin levels were noted and ranged from 17 to 3616 IU/l. Two… CONTINUE READING
12 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 12 extracted citations

Similar Papers

Loading similar papers…